BriefCase-Triage vs ElucidVivo A.3
AI Verdict
Choose BriefCase-Triage if…
Choose BriefCase-Triage if your primary need is to enhance overall radiology workflow efficiency by rapidly identifying and prioritizing a wide range of critical findings across various medical imaging studies. This tool is ideal for health systems aiming to reduce turnaround times for acute conditions and improve care coordination through real-time alerts and comprehensive triage capabilities.
View BriefCase-Triage →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if your clinical focus is on advanced, quantitative analysis of arterial plaque composition and stability from CT angiography to better stratify atherosclerosis patients. This solution is best suited for cardiologists and vascular surgeons who require detailed visualization and objective measurements of plaque characteristics to optimize treatment decisions and assess cardiovascular risk.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | BriefCase-Triage | ElucidVivo A.3 |
|---|---|---|
| Pricing | Enterprise pricing starts at approximately $50,000 per site per year. | Unknown |
| Deployment | Cloud-based. Aidoc's platform runs on AWS and Azure. The deployment process is described as lightweight, straightforward, and can be up and running in 2 to 3 weeks with minimal effort from facility IT. | Cloud and on-premise secure deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
| EHR Integration | Epic | Not specified |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | BriefCase-Triage | ElucidVivo A.3 |
|---|---|---|
| Name | BriefCase-Triage | ElucidVivo A.3 |
| Company | Aidoc | Elucid Bioimaging |
| Description | FDA-cleared AI solution for physicians, enhancing radiology workflows by rapidly detecting and prioritizing critical findings in medical images. | FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology. |
| Free Trial/Demo | yes, aidoc offers a free demo/consultation. | Not specified |
| Mobile App | Yes. Aidoc offers a mobile application for real-time notification of time-sensitive cases, built-in risk stratification, a mobile imaging viewer, and communication among care teams. | Not specified |
| Key Features | AI-powered analysis of medical imaging, Real-time alerts and notifications, Seamless integration with existing hospital systems (PACS, EHR), Prioritization of critical cases, Order-of-magnitude reduction in false alerts, Comprehensive triage solution (multiple indications in one workflow), Mobile app for care coordination, Continuous learning model | AI-powered quantitative analysis of arterial plaque, Objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, Visualizes lesion-level plaque composition, Provides 3D visualization of highlighted vessels, Offers rotatable curved MPR vessel views and cross-sections, Aids in stratifying patients with atherosclerosis, Derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity, Validated on ground-truth histology |
Videos
Demos, reviews, and walkthroughs featuring BriefCase-Triage and ElucidVivo A.3.
More Comparisons
More matchups featuring BriefCase-Triage or ElucidVivo A.3
Backers
Who funded each tool's parent company.